Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

3 articles from the last 90 days matching "long-read sequencing"

ResearchBIORXIVApr 4

Preprint: Targeted Long-Read sequencing provides functional validation of variants predicted to alter splicing

Researchers developed a new test called targeted long-read sequencing that can better identify which genetic changes affect how genes are read and used in cells. This test is more accurate than older methods at finding these changes in patients with neurological disorders, and it's faster and cheaper than previous approaches.

WHY IT MATTERSIf you have a neurological disorder where genetic testing hasn't found a clear diagnosis, this method could help doctors identify the actual genetic cause by better detecting splicing variants that standard tests miss.
Good to knowRead →
ResearchBIORXIVApr 3

Preprint: FA-NIVA: A Nextflow framework for automated analysis of Nanopore based long-read sequencing data for genetic analysis in Fanconi anemia

Scientists created a new computer tool called FA-NIVA that helps doctors find genetic mistakes in Fanconi anemia patients more accurately. Fanconi anemia is a rare inherited blood disorder caused by mistakes in specific genes. This new tool uses advanced DNA sequencing technology that reads longer pieces of DNA, making it easier to spot all types of genetic errors, including big deletions and insertions that older methods sometimes miss.

WHY IT MATTERSThis tool could help doctors diagnose Fanconi anemia more accurately and completely by detecting genetic variants that standard testing methods currently miss, potentially leading to faster diagnosis and better understanding of individual patient mutations.
Good to knowFanconi anemiaRead →
ResearchPUBMEDMar 26

[Resolving Genomic Mysteries with Long-read Sequencing].

Scientists are using a new technology called long-read sequencing that can read much longer pieces of DNA than older methods. This helps doctors find genetic causes of rare diseases that were previously missed, especially when mutations hide in repetitive parts of the genome or involve large structural changes. The technology is becoming an important tool in genetic testing labs worldwide.

WHY IT MATTERSIf you have a rare genetic disease that wasn't diagnosed by standard genetic testing, long-read sequencing may finally identify the genetic cause—potentially opening doors to targeted treatments and genetic counseling for your family.
💬 Ask your doctorRare genetic diseasesGenetic disorders with structural variantsInborn genetic diseasesRead →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases